Core Viewpoint - Microchip Technology Incorporated plans to offer $600 million in Convertible Senior Notes due 2030, with an option for an additional $90 million, aimed at qualified institutional buyers under Rule 144A of the Securities Act [1][6] Group 1: Offering Details - The notes will be senior, unsecured obligations of Microchip, with interest payable semi-annually [1] - Upon conversion, Microchip will pay cash up to the principal amount of the notes and may pay or deliver cash, shares of common stock, or a combination for any excess conversion obligation [1] - The interest rate, conversion rate, and other terms will be determined at the time of pricing [1] Group 2: Use of Proceeds - A portion of the net proceeds will be used to pay for capped call transactions with option counterparties [2] - If additional notes are purchased, proceeds will also fund further capped call transactions [2] - Remaining proceeds are intended for repaying outstanding notes under Microchip's commercial paper program [2] Group 3: Capped Call Transactions - Microchip expects to enter into capped call transactions to cover shares underlying the notes, aimed at reducing potential dilution upon conversion [4] - These transactions may offset cash payments exceeding the principal amount of converted notes [4] - The option counterparties may engage in purchasing shares or entering derivative transactions, potentially affecting the market price of Microchip's common stock [5]

SHANGHAI, Feb. 4, 2026 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China ("ZTO" or the "Company"), today announced the pricing of US$1.5 billion in aggregate principal amount of convertible senior notes due 2031 (the "Notes"). The Notes have been offered in offshore transactions outside the United States to non-U.S. persons that are "qualified institutional buyers" (as defined in Rule 144A under the United States Securities Ac ...

DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) ("Liberty†) today announced that it proposes to offer $500 million aggregate principal amount of convertible senior notes due 2031 (the "Notes†), subject to market conditions and other factors, in a private offering (the "Notes Offering†) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act†). Liberty also intends to grant the initial p. ...

Core Viewpoint - Arrowhead Pharmaceuticals, Inc. has announced the pricing of its concurrent public offerings, which include $625 million in convertible senior notes and 3,100,776 shares of common stock priced at $64.50 per share [1] Group 1: Public Offerings - The company is offering $625,000,000 aggregate principal amount of 0.00% convertible senior notes due in 2032 [1] - Additionally, the company is offering 3,100,776 shares of common stock at a public offering price of $64.50 per share [1] - For certain investors, pre-funded warrants are available at a public offering price of $64.499 per warrant, for up to 1,550 [1]

Core Viewpoint - Compass, Inc. plans to offer $750 million in convertible senior notes due 2031, with an option for initial purchasers to buy an additional $112.5 million within 13 days of issuance [1][2] Group 1: Offering Details - The notes will be senior unsecured obligations guaranteed by the Company's subsidiaries that also guarantee its existing revolving credit facility [2] - The net proceeds from the offering will be used for general corporate purposes, including repayment of existing indebtedness of Anywhere Real Estate Inc. if the merger is completed, and funding capped call transactions [2] Group 2: Conversion and Capped Call Transactions - The Company will satisfy conversion elections by paying cash, delivering shares of Class A common stock, or a combination of both at its discretion [3] - Capped call transactions are expected to reduce potential dilution of Class A common stock upon conversion of the notes and offset cash payments exceeding the principal amount of converted notes [4] Group 3: Market Impact and Hedging Activities - Counterparties may purchase shares of Class A common stock or enter into derivative transactions around the pricing of the notes, which could influence the market price of the stock and notes [5] - These activities may affect the ability of noteholders to convert the notes and the number of shares received upon conversion [5] Group 4: Company Overview - Compass is a leading tech-enabled real estate services company and the largest residential real estate brokerage in the U.S. by sales volume [7] - The Company provides an integrated platform for real estate agents, including cloud-based software for various critical functionalities [8]

Core Viewpoint - Arrowhead Pharmaceuticals, Inc. plans to offer $500 million in convertible senior notes due 2032 and $200 million in common stock, subject to market conditions [1] Group 1: Financial Offerings - The company intends to issue $500 million aggregate principal amount of convertible senior notes due 2032 [1] - Additionally, Arrowhead plans to offer $200 million of common stock in separate public offerings [1] - The underwriters of the note offering will have a 30-day option to purchase up to an additional $75 million [1]

Core Viewpoint - Realty Income Corporation plans to offer $750 million in convertible senior notes due 2029, with an option for initial purchasers to buy an additional $112.5 million [1][2]. Group 1: Offering Details - The notes will be senior, unsecured obligations, accruing interest payable semi-annually and maturing on January 15, 2029 [2]. - Noteholders can convert their notes under certain conditions, with conversions settled in cash and potentially shares of common stock [2]. - Realty Income can redeem the notes prior to maturity to maintain its status as a real estate investment trust for tax purposes [3]. Group 2: Corporate Events and Repurchase Rights - In the event of a "fundamental change," noteholders may require Realty Income to repurchase their notes for cash at the principal amount plus accrued interest [4]. Group 3: Use of Proceeds - The majority of net proceeds will be used for general corporate purposes, including repaying existing debt, property acquisitions, and share repurchases [6]. - Realty Income plans to repurchase shares of its common stock concurrently with the pricing of the offering, which may influence the trading price of its common stock [6]. Group 4: Company Overview - Realty Income, known as "The Monthly Dividend Company," has a portfolio of over 15,500 properties across the U.S. and other countries, and has a history of increasing dividends for over 30 consecutive years [9].

Core Viewpoint - Zoetis Inc. plans to offer $1.75 billion in convertible senior notes due 2029, subject to market conditions, targeting qualified institutional buyers under Rule 144A of the Securities Act [1] Group 1 - The offering amount is $1.75 billion in aggregate principal [1] - The notes will be convertible and are due in 2029 [1] - The offering is intended for persons reasonably believed to be qualified institutional buyers [1]

Core Points - CoreWeave (CRWV) announced a sale of $2 billion in convertible senior notes, leading to a nearly 5% decline in its share price [1][4] - The convertible senior notes will mature in 2031 and will be offered privately, with an option for initial investors to purchase an additional $300 million within 13 days of issuance [1][2] - Proceeds from the offering will be allocated for capped call transactions and general corporate purposes [2][4] Market Context - The announcement follows a recent decline in CoreWeave's shares amid concerns regarding an AI bubble, despite the stock having more than doubled since its initial public offering in March [3]

Core Viewpoint - Exelon Corporation plans to offer $900 million of convertible senior notes due 2029, with an option for initial purchasers to buy an additional $100 million within 13 days of issuance [1][2]. Group 1: Offering Details - The offering will be conducted as a private placement under the Securities Act of 1933 [1]. - The convertible notes will be senior unsecured obligations and convertible at the holders' option under certain conditions [3]. - Interest on the notes will be paid semiannually, and conversions will be settled in cash or common stock at Exelon's discretion [3]. Group 2: Use of Proceeds - Net proceeds from the offering will be used for debt repayment, refinancing, or general corporate purposes [2]. Group 3: Regulatory and Legal Considerations - The offering is targeted at qualified institutional buyers under Rule 144A, and the notes will not be registered under the Securities Act [4]. - The press release clarifies that it does not constitute an offer to sell or solicit an offer to buy the securities [5].